{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/66758-142#drug","name":"Exelon","alternateName":"rivastigmine","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"66758-142"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA022083"},{"@type":"PropertyValue","propertyID":"UNII","value":"PKI06M3IW0"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"b6ed6d15-116d-4596-92ce-3414574d7ba0"}],"activeIngredient":"RIVASTIGMINE","administrationRoute":["TRANSDERMAL"],"dosageForm":"PATCH, EXTENDED RELEASE","manufacturer":{"@type":"Organization","name":"Sandoz Inc"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA022083","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6ed6d15-116d-4596-92ce-3414574d7ba0","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66758-142"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T22:24:07.300Z"}}